Nordic Biomarker

Developing reagents for rapid detection of thrombosis - particle-enhanced immunoagglutination to quantify fibrin D-dimer fragments.

Already when a thrombus (blood clot formed in the blood vessels) is formed, fragments of fibrin are released from the clot. The smallest fragment, D-dimer, is an important biomarker for thrombosis. Particle-enhanced immunoagglutination is a suitable technique to make fast analyses of D-dimer with automated instruments in the hospital laboratories. In our project we have designed a production process for the bioreagents that are required to perform thetest. We have founded and initially financed a company, nordic biomarker, to produce andmarket the bioreagents to companies that are selling coagulation instruments to hospitalsaround the world.

G. Aronsson and G. Pohl
Nordic Biomarker AB, Box 3169,
903 04 Umeå, Sweden

www.nordicbiomarker.com